Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Naumann

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|September 21, 2001
Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantationU S Schuler, U D Renner, F Kroschinsky, et al.
Cancer Genetics and Cytogenetics|June 27, 2001
Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signalsB Mohr, M Bornhäuser, U Platzbecker, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2001
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphomaM Hänel, N Kröger, F Kroschinsky, et al.
British Journal of Cancer|February 5, 2004
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphomaR Naumann, B Beuthien-Baumann, A Reiss, et al.
Bone Marrow Transplantation|August 5, 2000
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulinM Bornhäuser, C Thiede, U Schuler, et al.
Gynecologic Oncology|February 28, 2024
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trialAnthony B Costales, Erin K Crane, Laura Chambers, et al.
Biointerphases|April 23, 2010
Solid supported lipid membranes: new concepts for the biomimetic functionalization of solid surfacesW Knoll, R Naumann, M Friedrich, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2023
Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of viewM Shalgouny, J Bertz-Lepel, L Fischer V Weikersthal, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)V Ballova, J-U Rüffer, H Haverkamp, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|September 21, 2001
Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantationU S Schuler, U D Renner, F Kroschinsky, et al.
Cancer Genetics and Cytogenetics|June 27, 2001
Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signalsB Mohr, M Bornhäuser, U Platzbecker, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2001
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphomaM Hänel, N Kröger, F Kroschinsky, et al.
British Journal of Cancer|February 5, 2004
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphomaR Naumann, B Beuthien-Baumann, A Reiss, et al.
Bone Marrow Transplantation|August 5, 2000
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulinM Bornhäuser, C Thiede, U Schuler, et al.
Gynecologic Oncology|February 28, 2024
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trialAnthony B Costales, Erin K Crane, Laura Chambers, et al.
Biointerphases|April 23, 2010
Solid supported lipid membranes: new concepts for the biomimetic functionalization of solid surfacesW Knoll, R Naumann, M Friedrich, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2023
Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of viewM Shalgouny, J Bertz-Lepel, L Fischer V Weikersthal, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)V Ballova, J-U Rüffer, H Haverkamp, et al.
Pageof 6